Journal article
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Abstract
Importance: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head to head.
Objective: To compare reported measures of efficacy and assessments of safety in clinical trials of systemic treatments for atopic dermatitis in a living systematic review and network meta-analysis.
Authors
Drucker AM; Morra DE; Prieto-Merino D; Ellis AG; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI
Journal
JAMA Dermatology, Vol. 158, No. 5, pp. 523–532
Publisher
American Medical Association (AMA)
Publication Date
May 1, 2022
DOI
10.1001/jamadermatol.2022.0455
ISSN
2168-6068